Middle East & Africa Oncology Drugs Market Size & Outlook

Name: Middle East & Africa Oncology Drugs Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The oncology drugs market in Middle East & Africa is expected to reach a projected revenue of US$ 16,390.0 million by 2033. A compound annual growth rate of 9.8% is expected of Middle East & Africa oncology drugs market from 2026 to 2033.

Pharmaceuticals
- Oncology Drugs
  - Oncology Drugs Market Outlook

Middle East & Africa oncology drugs drug class outlook (Revenue, USD million, 2021-2033)
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Hormonal Therapy
- Radiopharmaceuticals
- Cell & Gene Therapy
- Others
Middle East & Africa oncology drugs cancer outlook (Revenue, USD million, 2021-2033)
- Solid Tumors
- Hematologic Malignancies
Middle East & Africa oncology drugs route of administration outlook (Revenue, USD million, 2021-2033)
- Oral
- Injectable
- Others
Middle East & Africa oncology drugs drug outlook (Revenue, USD million, 2021-2033)
- Branded
- Generic & Biosimilar
Middle East & Africa oncology drugs distribution channel outlook (Revenue, USD million, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

Middle East & Africa Oncology Drugs Market Size & Outlook

Data Tree

Sign up - it's easy, and free!